Antegenes’ Projects for Public Health Improvement

The ability to identify those at increased risk based on their genotype has immediate clinical relevance, as it allows for tailored prevention or screening strategies. We have several active, ongoing programmes to develop personalised screening programme models to improve public health.

As demonstrated in the cases of breast, colorectal and prostate cancers, the combined effects of multiple risk single nucleotide polymorphisms have the potential to achieve a degree of risk discrimination that is useful for population-based prevention and screening programmes.